The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

By A. Hughes, S. Daniel, Y. Ben-Shlomo, Andrew Lees. Brain : a journal of neurology, 2002

1,226 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/8ad08dcd7ecd091a62a712637d6d524bd8b750e6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

Citations in the corpus

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. (2004, background): “…of Parkinson's disease, the UK PDS Brain Bank established a set of clinical criteria for diagnosing the condition, which have recently been shown to usefully predict the pathological diagnosis of Parkinson's disease in the hands of neurology specialists in movement disorders (Hughes et al., 2002).”
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. (2005, background): “Some of these cases have been included in previous clinical and pathological reviews from the SKRC (Daniel et al., 1995; Hughes et al., 2002; Morris et al., 2002; Gibb et al., 2004).”
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis (2020, background): “At the moment, its diagnosis is established on motor functions rating and other clinical signs, which can only be assessed when the loss of the DAergic neuron is approximately 70% [280].”
Evaluation of handwriting kinematics and pressure for differential diagnosis of Parkinson's disease (2016, methodology): “Even then the probability of an inaccurate diagnosis is approximately 25 % [4].”
Genetics of Parkinson disease: paradigm shifts and future prospects (2006, background): “A 'definite' diagnosis requires post mortem findings of neuronal loss and depigmentation of the substantia nigra , plus the presence of Lewy bodies (proteinaceous intracellular inclusions) in the brain stem, which together distinguish PD from other forms of parkinsonis”
Parkinson's disease and parkinsonism: neuropathology. (2012, methodology): “PD can be diagnosed with considerable accuracy, particularly by neurologists specializing in diagnosis and management of movement disorders (Hughes et al. 2002), when robust clinical criteria are used such as those of the Queen Square Parkinson Disease Brain Bank, which Figure 5.”